Ajanta Pharma : Q4FY17 result
Amir Shaikh / 03 May 2017
The company reported PAT of Rs 114 crore, which represents a sequential QoQ decline of 20.06 per cent and a YoY increase of 4.63 per cent.
Ajanta Pharma Ltd reported its results for the quarter ended March 31, 2017 today.
The company's total sales for Q4FY17 came in at Rs 476.81 crore, which represents a 10.56 per cent sequential decline and 10.73 per cent YoY increase.
Its revenue from India business witnessed an increase of 13 per cent YoY, which was led by 19 per cent and 18 per cent YoY growth in ophthalmology and cardiology, respectively. Also, its total export during the quarter rose 6 per cent YoY.
The company's operating profit (EBIT) for the quarter was Rs 142.48 crore, while its EBIT margin stood at 29.88 per cent.
The company reported PAT of Rs 114 crore, which represents a sequential QoQ decline of 20.06 per cent and a YoY increase of 4.63 per cent.
The company's stock opened for trading at Rs 1657.5 on the BSE, rose 1.3 per cent after the results were declared and closed for the day at Rs 1666.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.